Schaper Benz & Wise Investment Counsel Inc Exact Sciences Corp Transaction History

Schaper Benz & Wise Investment Counsel Inc

$1.21 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	BUY	$62.68 - $95.05 $137,896 - $209,110	2,200 New	2,200 $206,000
Q2 2022 Aug 04, 2022	SELL	$35.61 - $76.23 $124,100 - $265,661	-3,485 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$57.56 - $82.54 $17,268 - $24,762	300 Added 9.42%	3,485 $244,000
Q4 2021 Feb 10, 2022	SELL	$72.5 - $100.68 $14,500 - $20,136	-200 Reduced 5.91%	3,185 $248,000
Q1 2021 Apr 20, 2021	BUY	$116.57 - $155.01 $34,971 - $46,503	300 Added 9.72%	3,385 $446,000
Q2 2020 Jul 30, 2020	BUY	$55.75 - $92.75 $171,988 - $286,133	3,085 New	3,085 $268,000
Q1 2020 May 04, 2020	SELL	$37.9 - $104.44 $116,921 - $322,197	-3,085 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$77.66 - $99.74 $239,581 - $307,697	3,085 New	3,085 $285,000
Q1 2019 Apr 23, 2019	SELL	$61.98 - $96.5 $241,722 - $376,350	-3,900 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$56.04 - $82.66 $10,031 - $14,796	179 Added 4.81%	3,900 $246,000
Q2 2018 Aug 06, 2018	BUY	$37.84 - $69.96 $140,802 - $260,321	3,721 New	3,721 $222,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.01 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$898 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$812 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$684 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$379 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schaper Benz & Wise Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schaper Benz & Wise Investment Counsel Inc with notifications on news.

Account